Would you be interested in checking KVPHQ? I have bought some a few months ago. It's a biotech with a drug named Makena. March revenue was 7 million and 0 to 30 day receiveable is 16 million dollars. The went to BK just at the wrong time and as soon as they did, their issues started getting resolved. the more the company stays in bk, its better for the equity. I think. KVPHARMA.COM is their website. EPIQ has their court info. In yahoo, check the messages from cancunfish. Only very few people involved for the last several months in the discussion of the stock. Last year 50 people died because of meningitis. Compounders produced alternative drug to Makena which was very in expensive but turned out to be deadly. The news was all over, including CBS 60 minutes. Now states are ready to pay 600 dollars per Makena. I do not have enough experience understanding of court procedures to be certain about what will happen with KVPHQ stockholders but one thing I have noted from reading an article about equity recovery cases - is the current income stream should be getting better and better for equity to recover through POR during BK and a leader in a niche market (makena as only approved FDA drug). And here we have the case. The future of this company depends on who will inspect and control the compounding industry. Currently compounders don't give a damn about FDA inspectors as they say they are beyond FDA's jurisdiction. Will see. But check cancunfish's messages..he probably has about 20 of them.
Market Data 
Markets 
